NCT06037395 Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT05993806 A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05906992 A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis Status RECRUITING Phase PHASE3
NCT05866614 A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05725434 A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis Status UNKNOWN Phase PHASE3
NCT05617183 Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects Status UNKNOWN Phase PHASE1
NCT05581693 A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05568121 A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05495568 To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT05489224 A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT05385770 Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects Status COMPLETED Phase PHASE3
NCT05364164 A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05363592 A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05363384 A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05224856 To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen Status WITHDRAWN Phase PHASE3
NCT05188378 A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects Status UNKNOWN Phase PHASE1
NCT05072782 Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) Status UNKNOWN Phase PHASE4
NCT05017168 To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05009368 A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT05002244 A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers Status COMPLETED Phase PHASE1